Comparison of Blood Loss in Holmium Laser Enucleation of the Prostate (HoLEP) Versus Transurethral Resection of Prostate (TURP)

Abstract

Objective: To assess the amount of blood lost by BPH patients receiving holmium laser prostate enucleation (HoLEP) surgery vs transurethral prostate resection (TURP).

Study Design: Observational / experimental study.

Place and Duration of Study: This study was conducted at the Foundation University Medical College, Rawalpindi from June 2022 and November 2022.

Materials and Methods: Two groups of forty BPH patients each were prospectively divided into Groups I and Group II. Patients in group I underwent HoLEP, while those in group II underwent TURP. Hemoglobin (Hb) measurements were made before to surgery and on the first postoperative day to gauge blood loss.

Results: Forty patients from the HoLEP group I and TURP group II were considered in this study. The hemoglobin loss was 0.26 ± 0.05 in group I and 0.71 ± 0.124 in group II. Hemoglobin levels dropped substantially less in the group I than in the group II.

Conclusion: Hemoglobin (Hb) level dropped after prostate surgery was substantially less in HoLEP than in TURP. We come to the conclusion that HoLEP is a very effective with low complications operation in patients with prostate enlargement in light of the elevated risk of bleeding.